TRHC’s CareVention HealthCare™ Begins Medication Safety and Pharmacy Services for Silver Star PACE in Lubbock, Texas

MOORESTOWN, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, began services with Silver Star PACE on October, 2019 through its CareVention HealthCare™ Division. CareVention will deliver medication safety and pharmacy services, along with the electronic health record and health plan management services that are already in place. Silver Star PACE provides care to nearly 200 participants in Lubbock, Texas.

PACE (Program of All-Inclusive Care for the Elderly) organizations nationwide rely on TRHC technology, services and consulting to optimize outcomes and maintain regulatory compliance. The company’s medication safety and pharmacy services, featuring proprietary Medication Risk Mitigation software and pharmacists who are board-certified in geriatrics, improve medication outcomes, increase adherence, and reduce participant hospitalizations.

“TRHC is honored to expand this partnership with Silver Star PACE,” said TRHC President Orsula V. Knowlton, PharmD. “Our pharmacy services help reduce the risk of adverse drug events, the third leading cause of death in the United States; enhance quality; and lower health costs.”

Silver Star PACE provides care for PACE participants through comprehensive coordinated medical care and provides training, support groups, and respite opportunities for caregivers. Silver Star’s mission is to enhance the quality of life not only for participants in the program, but also for family members and caregivers by providing convenience, peace-of-mind and high-quality care.

“Silver Star PACE is dedicated to providing excellent healthcare and support services, ensuring quality lifestyles for every client we serve,” states Joanne Harwood. “We are thrilled to be collaborating with TRHC for products and services that deliver high-quality care to our participants and their families.”

PACE is a federal program that provides comprehensive medical and social services to individuals 55 and older who are nursing-home eligible. There are 130 PACE programs operating 260 PACE centers serving more than 51,000 participants in 31 states. The goal of PACE is to keep participants living in their own communities while receiving quality care at home.

About CareVention HealthCare

CareVention HealthCare offers comprehensive, integrated solutions and services for organizations at every stage of PACE (Programs of All-inclusive Care for the Elderly), from exploring PACE at the state and organizational levels, through start-up and ongoing operations. Medication management and pharmacy distribution services are offered by TRHC’s CareKinesis Division. CareVention HealthCare provides end-to-end services to assure regulatory compliance, participant health and safety, and optimized financial management. For more information, visit .

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications, including EireneRx® and MedWise™, provide solutions for a range of payers, providers and other healthcare organizations. For more information please visit,

Forward-Looking Statement

This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the Securities and Exchange Commission (“SEC”), including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website or upon request from our Investor Relations Department. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.